Results of social research on assessing the needs for pharmaceutical personnel
Main Article Content
Keywords
Pharmaceutical workforce, recruitment challenges, skills gaps, medical-pharmaceutical clusters, professional competencies
Abstract
The pharmaceutical industry in Kazakhstan faces increasing demand for qualified personnel caused by rapid technological developments, changes in the regulatory environment and the growing role of inter-organizational collaboration. At the same time, there is a shortage of professional specialists, which complicates personnel recruitment and requires a rethinking of personnel policies. Aim of the study: To analyse the current workforce distribution, educational level, personnel recruitment issues, and professional skills requirements, as well as to develop recommendations to overcome personnel challenges in the pharmaceutical industry. Methods: The survey covered demographic data, professional roles, recruitment issues, skill requirements and prospects for collaboration in the pharmaceutical industry. Four hundred twenty-three people participated, of which 405 valid questionnaires remained after excluding incomplete responses. Data were collected through a secure online platform, and from paper forms, they were entered manually. The analysis aimed to identify trends in the workforce composition, recruitment issues and key skill requirements. Results: The survey identified significant gaps in staffing, the most in-demand skills and key competencies, and the relevance of inter-organizational interaction strategies. The study results highlight the need to develop comprehensive approaches to solving recruitment problems, improving educational programs, and adapting HR policies to the current needs of the industry.
References
2. Zhakipbekov K, Posylkina O, Zhumabayev N, Datkhayev U, Zhumabayev N, Almurzaeva A, Mukanova A. Analysis of the current state of the pharmaceutical market of the Republic of Kazakhstan. ScienceRise: Pharmaceutical Science [Internet]. 2023 Apr 30 [cited 2024 Oct 29];(2(42)):57-6. Available from: https://journals.uran.ua/sr_pharm/article/view/267787
3. Pharm Reviews. [Pharmaceutical production in Kazakhstan in the first half of 2024]. PharmReviews.kz. 2024 Aug 22. Available from: https://pharmreviews.kz/analitika/proizvodstvo-farmatsevticheskoj-produktsii-v-rk-v-i-polugodii-2024-goda. Russian.
4. Birkie SE, Trucco P. Understanding dynamism and complexity factors in engineer-to-order and their influence on lean implementation strategy. Production Planning & Control. 2020;27(5):345-359.
5. Bonn I, Christodoulou C. From strategic planning to strategic management. Long Range Planning. 2019;29(4):543-551.
6. Cambra-Fierro JJ, Centeno E, Olavarria A, Vazquez-Carrasco R. Success factors in a CRM strategy: technology is not all. Journal of Strategic Marketing. 2017;25(4):316-333.
7. Ministry of Health of the Republic of Kazakhstan. Title of the webpage in English translation. Government of Kazakhstan. [Webpage in Russian]. Available from: https://www.gov.kz/memleket/entities/dsm/press/news/details/524849?lang=ru. Accessed 2024 Oct 4.
8. Poskey M. Seven Steps to Increase Employee Retention. IRMI. 2013 May. Available from: https://www.irmi.com/articles/expert-commentary/seven-steps-to-increase-employee-retention. Accessed 2024 Dec 20.
9. Minnesota Hospital Association. Employee Retention Tool Kit. Minnesota Hospital Association. 2013. Available from: http://www.mnhospitals.org/policy-advocacy/priority-issues/developing-a-future-workforce/employee-retention-toolkit. Accessed 2024 Dec 24.
10. Thilagham KT, TN M, Tirumala P, Datta A, Bhadauria GS, Agarwal P. STUDY ON TALENT MANAGEMENT PRACTICES IN PHARMA SECTOR WITH FOCUS ON EMPLOYEE RETENTION. Journal of Pharmaceutical Negative Results. 2022:1366-1376.
11. Anakwe UP. Human resource management practices in Nigeria: challenges and insights. International Journal of Human Resource Management. 2002;13(7):1042-1059. doi:10.1080/09585190210131285.
12. Sheridan J. Organizational Culture and Employee Retention. Academy of Management Journal. 1992;35(5):1036-1056.
13. Acton T, Golden W. Training the knowledge worker: A descriptive study of training practices in Irish software companies. Journal of Eur. Ind. Train. 2003;27(4):137-146.
14. Khan MM, Jabbar M. Determinants of Employees Performance in Corporate Sector: Case of an Emerging Market. Business and Management Research. 2013;2(3):25-32.
15. Association for the Development of the Pharmaceutical Industry of Kazakhstan. Chto neobkhodimo dlya razvitiya otechestvennoy farmatsevticheskoy industrii? [What Is Needed for the Development of the Domestic Pharmaceutical Industry?]. Association for the Development of the Pharmaceutical Industry of Kazakhstan. [Webpage in Russian]. Available from: https://aprfd.kz/index.php/novosti/item/2756-chto-neobkhodimo-dlya-razvitiya-otechestvennoj-farmatsevticheskoj-industrii. Accessed 2025 Jan 5.
16. International Pharmaceutical Federation. Pharmaceutical workforce development goals. International Pharmaceutical Federation. 2016. Available from: https://fip.org/files/fip/PharmacyEducation/2016_report/2016-11-Education-workforce-development-goals.pdf.
17. International Pharmaceutical Federation. FIP and CPA cement relations. International Pharmaceutical Federation. 2018. Available from: https://www.fip.org//news?news=newsitem&newsitem=265. Accessed 2021 Nov 26.
18. Arruda W. LinkedIn 201: How To Cultivate A Powerful Network. Forbes. 2017 Feb 5. Available from: https://www.forbes.com/sites/williamarruda/2017/02/05/linkedin-201-how-to-cultivate-a-powerful-network.
19. Qyzmet.kz. Официальный сайт. [Official Website]. Available from: https://qyzmet.kz. Accessed 2024 Oct 1.
20. Enbek.kz. Официальный сайт. [Official Website]. Available from: https://enbek.kz. Accessed 2024 Oct 1.
21. HeadHunter.kz. Официальный сайт. [Official Website]. Available from: https://hh.kz. Accessed 2024 Oct 1.
22. Oljabayeva KB. Nekotorye defekty zakonodatel’stva o trude meditsinskikh i farmatsevticheskikh rabotnikov i puti ikh ustraneniya [Some defects in labor legislation for medical and pharmaceutical workers and ways to address them]. Bulletin of the Institute of Legislation and Legal Information of the Republic of Kazakhstan. 2022;(1(68)):138–145.
23. Yegizbayeva ShA, Zhumabayev NN, Zhakipbekov KS, Zhumabaev NZh, Posylkina OV, Umurzakhova GZh, Serikbaeva EA, Konash NYe. Analiz sovremennogo sostoyaniya farmatsevticheskogo rynka Respubliki Kazakhstan [Analysis of the current state of the pharmaceutical market in the Republic of Kazakhstan]. Vestnik Instituta zakonodatel’stva i pravovoi informatsii Respubliki Kazakhstan. 2024;1(68):271–285. doi:10.53511/pharmkaz.2024.57.23.033.
24. SK-Pharmacy LLP. Strategiya razvitiya 2024–2028 [Development strategy 2024–2028]. SK-Pharmacy LLP. 2024. Russian. Available from: https://sk-pharmacy.kz/files4/Стратегия/04.05.2024/СТРАТЕГИЯ%202024-2028_12_03_2024_рус.docx. Accessed 2025 Jan 5.
25. DeChant AK, Fening S, Haag M, Harte W, Chance MR. Optimizing biomedical discoveries as an engine of culture change in an academic medical center. Journal of Clinical and Translational Science. 2022;6(1):e19. doi:10.1017/cts.2021.888
26. Alberti FG, Giusti JD, Papa F, Pizzurno E. Competitiveness policies for medical tourism clusters: government initiatives in Thailand. International Journal of Economic Policy in Emerging Economies. 2014;7(3):281–309.
27. Koo J, Choi J. The rise of the biomedical cluster in Wonju, Korea. In: Eriksson S, editor. Clusters and Economic Growth in Asia. Edward Elgar Publishing; 2013. p. 66–84.
28. Islankina EA, Kutsenko ES, Filina FN, Pankevich VI, et al. Biomeditsinskie klastery v mire: faktory uspekha i istorii luchshikh [Biomedical clusters in the world: success factors and stories of the best]. Moscow: NIU VShE; 2019. 160 p. Russian.
29. Braunerhjelm P, Carlsson B, Cetindamar D, Johansson D. The old and the new: The evolution of polymer and biomedical clusters in Ohio and Sweden. Journal of Evolutionary Economics. 2000;10(5):471–488; Cooke P. Biotechnology clusters as regional, sectoral innovation systems. International Regional Science Review. 2002;25(1):8–37.
